Semaglutide : Stimulates only the GLP-1 receptor, promoting insulin release, lowering blood sugar, and reducing appetite
It has multiple actions including: stimulating insulin secretion (when blood glucose is elevated), suppressing glucagon secretion, slowing gastric emptying (so food stays in the stomach longer) and reducing appetite/food intake via central nervous system effects
doi: 10.1055/s-0032-1328877 44 KhorramiAGhanbarzadehSZiaeeMAramiSVajdiRGarjaniA
The active ingredient in Wegovy is semaglutide, a drug first approved for treating type 2 diabetes
In addition to its weight loss benefits, Semaglutide has proven to be an effective tool in lowering blood sugar levels for patients with type 2 diabetes
Through Pandameds.com Canada, Ozempic costs $379.99 per month for a 4-week supply at any dose